3 biotech IPOs, $703M raised for clinical trials

The latest stories trending on MedCity News.

Editor's Pick

Top Story 3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders Bicara Therapeutics' IPO raised $315 million raised for Phase 3 testing of a bifunctional antibody drug with potential to become a first-line treatment for head and neck cancers. Zenas BioPharma and MBX Biosciences also went public; all three companies upsized their IPOs. Sponsored Accelerating Claim Processing: Strategies to Shorten the Life of a Claim Presented by Greenway Health These strategies and practices can significantly shorten the life cycle of claims, leading to quicker resolutions and improved financial outcomes.  Learn More. A Few Spots Are Left for INVEST Digital Health We're down to the wire and only have a few spaces left —register now to secure your place at the forefront of digital health transformation. We can't wait to see you Wednesday, September 18, at Pegasus Park in Dallas. Get Your Ticket TODAY

Featured News

Why Former FDA & Verily Exec Amy Abernethy Is Launching a New Venture This week, longtime healthcare veterans Amy Abernethy and Brad Hirsch teamed up to launch Highlander Health — a Dallas-based startup focused on accelerating clinical evidence generation. Charlie Health Partners with Cartwheel to Address the Student Mental Health Crisis Through a new partnership, students at schools within Cartwheel's network in need of higher acuity care can access treatment through Charlie Health. A Closer Look at FIT Tests - A Primer on the Various Options for Colorectal Cancer Screening As we confront the sobering statistics and growing impact of colorectal cancer, it's clear that more education about the various options for testing is needed to increase screening rates across the U.S. Improved Access to CGM Data Empowers Providers and Patients to More Effectively Partner on  Diabetes Management Continuous Glucose Monitoring tools are revolutionizing the way diabetes is managed, offering unparalleled benefits for both healthcare providers and patients. By providing continuous, accurate data, CGM is especially useful for remote monitoring, enabling timely interventions and leading to better user health. The Apple AirPods Pro Have a New Hearing Feature, Yet the Biggest Impact May be to Protect Us All From Noise Apple's new Loud Sound Reduction capability scans the environment 46,000 times a second for sudden peaks in sound, reducing them to a safe level.

Resources

Debunked | No-Fluff Healthcare News Show | Presented by MedCity News | Episode 8 In this episode, we address a judge's ruling against FTC's ban on non-compete clauses in employment contracts and its implications for healthcare workers. Also, Pfizer's launch of a digital platform providing easy access to providers and medications for migraine patients and vaccine seekers. Finally, Johnson & Johnson's attempt to modify its 340B drug discount program, which offers reduced prices on outpatient medications to hospitals serving uninsured patients. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe